1. Home
  2. Primary Antibodies

Search Result - Primary Antibodies

  • anti-CD19 antibody [LT19] (PerCP)
  • Cat. No: ARG53784 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone LT19 reacts with CD19 (B4), a 95 kDa type I transmembrane glycoprotein (immunoglobulin superfamily) expressed on B lymphocytes and follicular dendritic cells; it is lost on plasma cells.
  • Conjugation: PerCP
  • anti-CD1a antibody [HI149] (APC)
  • Cat. No: ARG53785 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone HI149 reacts with CD1a (T6), a 49 kDa polypeptide associated with beta2-microglobulin expressed on cortical thymocytes (strongly), Langerhans cells, dendritic cells and some T cell leukemias and lymphomas.
    does not react with peripheral blood T and B lymphocytes, monocytes, granulocytes, platelets and erythrocytes.
    HLDA V; WS Code CD01.01
  • Conjugation: APC
  • anti-CD2 antibody [LT2] (APC)
  • Cat. No: ARG53787 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone LT2 reacts with CD2, a 50 kDa glycoprotein present on the human peripheral blood T lymphocytes and NK cells; also expressed by all thymocytes.
    HLDA VI; WS Code T 6T-008
  • Conjugation: APC
  • anti-CD2 antibody [MEM-65] (PE)
  • Cat. No: ARG53788 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone MEM-65 recognizes an unique epitope of CD2, a 50 kDa glycoprotein present on the human peripheral blood T-lymphocytes and NK cells; also expressed by all thymocytes.
    HLDA VI; WS Code T 6T-012
  • Conjugation: PE
  • anti-CD20 antibody [LT20] (APC)
  • Cat. No: ARG53790 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone LT20 reacts with CD20 (Bp35), a 33-37 kDa non-glycosylated membrane receptor with four transmembrane domains, expressed on B lymphocytes (it is lost on plasma cells), follicular dendritic cells, and at low levels on peripheral blood T lymphocytes.
  • Conjugation: APC
  • anti-CD22 antibody [IS7] (APC)
  • Cat. No: ARG53792 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone IS7 reacts with CD22 (BL-CAM), a 130 kDa type I transmembrane glycoprotein (immunoglobulin superfamily) expressed in the cytoplasm of pro-B and pre-B lymphocytes, and on the surface of mature and activated B lymphocytes; it is lost on plasma cells, peripheral blood T lymphocytes, granulocytes and monocytes.
    HLDA IV; WS Code B 227
    HLDA V; WS Code B CD22.8
  • Conjugation: APC
  • anti-CD229 antibody [HLy9.25] (APC)
  • Cat. No: ARG53796 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone HLy9.25 (also known as HLy9.1.25) recognizes CD229 / Ly9, a 100-120 kDa cell surface glycoprotein expressed on T and B cells.
  • Conjugation: APC
  • anti-CD229 antibody [HLy9.25] (PE)
  • Cat. No: ARG53797 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone HLy9.25 (also known as HLy9.1.25) recognizes CD229 / Ly9, a 100-120 kDa cell surface glycoprotein expressed on T and B cells.
  • Conjugation: PE
  • anti-CD230 / Prion protein antibody [EM-20]
  • Cat. No: ARG53798 　(Mouse mAb)
  • Reactivity: Hu
  • Application: WB
  • Specificity: The clone EM-20 recognizes human prion protein (PrP). Diglycosylated form of PrP has ~ 40 kDa, monoglycosylated form ~ 30 kDa, and nonglycosylated form ~ 19-21 kDa. This antibody is suitable for discrimination between normal cellular prion protein (PrPc) and its conformationally changed form (PrPSc) prion protein.
  • Conjugation: Un-conjugated
  • anti-CD235a antibody [HIR2] (PE)
  • Cat. No: ARG53799 　(Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone HIR2 recognizes N-terminal portion of glycophorin A (and weakly of glycophorin B). Its antigen is expressed on early erythroblasts, late erythroblasts, erythroblasts, mature erythrocytes and the cells of erythroid cell lines K562 and HEL, but not on all other cells.
    HLDA VII; WS Code 70299
  • Conjugation: PE
arigo nuts about antibodies
© 2014-2025, arigo Biolaboratories Corp., All rights reserved